Tags

Type your tag names separated by a space and hit enter

Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study.
J Sex Med. 2013 Nov; 10(11):2832-41.JS

Abstract

INTRODUCTION

There is partial evidence to support the use of phophodiesterase-5 inhibitor (PDE5-I) for the treatment of premature ejaculation (PE).

AIM

We compared on-demand dosing of dapoxetine alone and combined with mirodenafil in subjects with lifelong PE and without erectile dysfunction (ED).

METHODS

Our prospective, randomized, double-blind, placebo-controlled, multicenter trial enrolled 118 subjects with lifelong PE without ED. PE was diagnosed using Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision. Patients were divided into two groups: dapoxetine 30 mg plus placebo (group A, n=56) and dapoxetine 30 mg plus mirodenafil 50 mg (group B, n=62).

MAIN OUTCOME MEASURES

During 12 weeks, intravaginal ejaculatory latency time (IELT) and the time from foreplay to beginning intercourse (FTIT) with a stopwatch, and Premature Ejaculation Profile (PEP) were measured. Overall sexual act time (OSAT; sum of FTIT and IELT) was calculated. Any treatment-emergent adverse events (TEAEs) were also recorded.

RESULTS

Over 12 weeks, IELT, OSAT, and PEP index score significantly improved in group B compared with group A (increased geometric mean IELT in group A and B=3.6 and 6.1 minutes, P=0.026; increased geometric mean OSAT in group A and B=5.5 and 9.9 minutes, P=0.012; increased median PEP index score in group A and B=1.0 and 1.3, P=0.046). However, there was no significant difference between two groups with respect to improvement of FTIT (P=0.147). TEAEs did not differ between groups (all P>0.05), and there was no serious adverse event in any subjects.

CONCLUSIONS

Low dose of dapoxetine combined with mirodenafil showed better results in terms of IELT, OSAT, and PEP index score, and similar TEAEs, compared with that of dapoxetine only. Our results support the suggestion that the PDE5-Is have a potential role in the treatment of PE without ED.

Authors+Show Affiliations

Department of Urology, College of Medicine, Hallym Unversity, Chuncheon Sacred Heart Hospital, Chuncheon, Korea.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Multicenter Study
Randomized Controlled Trial

Language

eng

PubMed ID

23937271

Citation

Lee, Won Ki, et al. "Comparison Between On-demand Dosing of Dapoxetine Alone and Dapoxetine Plus Mirodenafil in Patients With Lifelong Premature Ejaculation: Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Study." The Journal of Sexual Medicine, vol. 10, no. 11, 2013, pp. 2832-41.
Lee WK, Lee SH, Cho ST, et al. Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study. J Sex Med. 2013;10(11):2832-41.
Lee, W. K., Lee, S. H., Cho, S. T., Lee, Y. S., Oh, C. Y., Yoo, C., Cho, J. S., Lee, S. K., & Yang, D. Y. (2013). Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study. The Journal of Sexual Medicine, 10(11), 2832-41. https://doi.org/10.1111/jsm.12287
Lee WK, et al. Comparison Between On-demand Dosing of Dapoxetine Alone and Dapoxetine Plus Mirodenafil in Patients With Lifelong Premature Ejaculation: Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Study. J Sex Med. 2013;10(11):2832-41. PubMed PMID: 23937271.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study. AU - Lee,Won Ki, AU - Lee,Seong Ho, AU - Cho,Sung Tae, AU - Lee,Yong Sung, AU - Oh,Cheol Young, AU - Yoo,Changhee, AU - Cho,Jin Seon, AU - Lee,Sang Kon, AU - Yang,Dae Yul, Y1 - 2013/08/12/ PY - 2013/8/14/entrez PY - 2013/8/14/pubmed PY - 2014/10/7/medline KW - Dapoxetine KW - Intravaginal Ejaculatory Latency Time KW - Mirodenafil KW - Premature Ejaculation SP - 2832 EP - 41 JF - The journal of sexual medicine JO - J Sex Med VL - 10 IS - 11 N2 - INTRODUCTION: There is partial evidence to support the use of phophodiesterase-5 inhibitor (PDE5-I) for the treatment of premature ejaculation (PE). AIM: We compared on-demand dosing of dapoxetine alone and combined with mirodenafil in subjects with lifelong PE and without erectile dysfunction (ED). METHODS: Our prospective, randomized, double-blind, placebo-controlled, multicenter trial enrolled 118 subjects with lifelong PE without ED. PE was diagnosed using Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision. Patients were divided into two groups: dapoxetine 30 mg plus placebo (group A, n=56) and dapoxetine 30 mg plus mirodenafil 50 mg (group B, n=62). MAIN OUTCOME MEASURES: During 12 weeks, intravaginal ejaculatory latency time (IELT) and the time from foreplay to beginning intercourse (FTIT) with a stopwatch, and Premature Ejaculation Profile (PEP) were measured. Overall sexual act time (OSAT; sum of FTIT and IELT) was calculated. Any treatment-emergent adverse events (TEAEs) were also recorded. RESULTS: Over 12 weeks, IELT, OSAT, and PEP index score significantly improved in group B compared with group A (increased geometric mean IELT in group A and B=3.6 and 6.1 minutes, P=0.026; increased geometric mean OSAT in group A and B=5.5 and 9.9 minutes, P=0.012; increased median PEP index score in group A and B=1.0 and 1.3, P=0.046). However, there was no significant difference between two groups with respect to improvement of FTIT (P=0.147). TEAEs did not differ between groups (all P>0.05), and there was no serious adverse event in any subjects. CONCLUSIONS: Low dose of dapoxetine combined with mirodenafil showed better results in terms of IELT, OSAT, and PEP index score, and similar TEAEs, compared with that of dapoxetine only. Our results support the suggestion that the PDE5-Is have a potential role in the treatment of PE without ED. SN - 1743-6109 UR - https://www.unboundmedicine.com/medline/citation/23937271/Comparison_between_on_demand_dosing_of_dapoxetine_alone_and_dapoxetine_plus_mirodenafil_in_patients_with_lifelong_premature_ejaculation:_prospective_randomized_double_blind_placebo_controlled_multicenter_study_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1743-6095(15)30190-9 DB - PRIME DP - Unbound Medicine ER -